Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results

Go back to Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results
(NASDAQ: DNTH) Delayed: 87.53 +0.16 (0.18%)
Previous Close $87.37    52 Week High
Open $86.41    52 Week Low
Day High $88.97    P/E N/A 
Day Low $84.61    EPS
Volume 969,194